MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
Conditions: Leiomyosarcoma; Liposarcoma; Synovial Sarcoma; Angiosarcoma; Undifferentiated Pleomorphic Sarcoma; Epithelioid Sarcoma; Malignant Peripheral Nerve Sheath Tumors; Fibrosarcoma; Pleomorphic Rhabdomyosarcoma; Endometrial Stromal Sarcoma; Desmoplastic Small Round Cell Tumor Interventions: Biological: MASCT-I; Drug: Doxorubicin; Drug: Ifosfamide Sponsors: HRYZ Biotech Co. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 26, 2024 Category: Research Source Type: clinical trials
Treatment of BRAF ( B-Rapidly Accelerated Fibrosarcoma) Mutated Papillary Craniopharyngioma
Condition: Craniopharyngioma Intervention: Drug: Oral dabrafenib and trametinib Sponsors: Eva Marie Erfurth, MD, PhD; Novartis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2022 Category: Research Source Type: clinical trials
Registry For Children, Adolescents And Adults With Osteosarcoma And Biologically Related Bone Sarcomas
Conditions: Osteosarcoma; Bone Tumor; Bone Sarcoma; High Grade Sarcoma; Osteoblastic Osteosarcoma; Chondroblastic Osteosarcoma; Fibroblastic Osteosarcoma; Conventional Osteosarcoma; Conventional Central Osteosarcoma of Bone; Low Grade Central Osteosarcoma; Osseou s Sarcoma; Osseous Tumor; Small Cell Osteosarcoma; Telangiectatic Osteosarcoma; Undifferentiated Pleomorphic Sarcoma; Parosteal Osteosarcoma; Periosteal Osteosarcoma; Extraskeletal Osteosarcoma; Recurrent Osteosarcoma; High Grade Surface Osteosarcoma; Osse ous Angiosarcoma...
Source: ClinicalTrials.gov - August 25, 2022 Category: Research Source Type: clinical trials
